Academic Journal
Polyunsaturated fatty acid-derived lipid mediator patterns determine viral pneumonia severity and risk for critical COVID-19.
| Τίτλος: | Polyunsaturated fatty acid-derived lipid mediator patterns determine viral pneumonia severity and risk for critical COVID-19. |
|---|---|
| Συγγραφείς: | Papadaki M; Laboratory of Immunobiology, Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens 11527, Greece., Pavlos E; Laboratory of Immunobiology, Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens 11527, Greece.; Division of Basic Sciences, University of Crete Medical School, Heraklion 71110, Greece., Dubourdeau M; Ambiotis Société par Actions Simplifiée, Toulouse 31400, France., Bailif V; Ambiotis Société par Actions Simplifiée, Toulouse 31400, France., Badirou K; Ambiotis Société par Actions Simplifiée, Toulouse 31400, France., Gély CA; Ambiotis Société par Actions Simplifiée, Toulouse 31400, France., Galani IE; Laboratory of Immunobiology, Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens 11527, Greece., Papelis D; Division of Pharmacology-Pharmacotechnology, Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens 11527, Greece., Kamperi N; Division of Pharmacology-Pharmacotechnology, Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens 11527, Greece., Triantafyllia V; Laboratory of Immunobiology, Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens 11527, Greece., Siouti E; Laboratory of Immunobiology, Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens 11527, Greece., Salagianni M; Laboratory of Immunobiology, Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens 11527, Greece., Manioudaki M; Laboratory of Immunobiology, Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens 11527, Greece., Paschalidis N; Center of Basic Research, Biomedical Research Foundation of the Academy of Athens, Athens 11527, Greece.; Greek Genome Center, Biomedical Research Foundation Academy of Athens, Athens 11527, Greece., Vatsellas G; Center of Basic Research, Biomedical Research Foundation of the Academy of Athens, Athens 11527, Greece.; Greek Genome Center, Biomedical Research Foundation Academy of Athens, Athens 11527, Greece., Koukaki E; Intensive Care Unit, 1st Department of Respiratory Medicine, National and Kapodistrian University of Athens, Medical School, 'Sotiria' General Hospital of Chest Diseases, Athens 11527, Greece., Rapti V; 3rd Department of Internal Medicine, 'Sotiria' General Hospital of Chest Diseases, National and Kapodistrian University of Athens, Athens 11527, Greece., Thanos D; Center of Basic Research, Biomedical Research Foundation of the Academy of Athens, Athens 11527, Greece.; Greek Genome Center, Biomedical Research Foundation Academy of Athens, Athens 11527, Greece., Rovina N; Intensive Care Unit, 1st Department of Respiratory Medicine, National and Kapodistrian University of Athens, Medical School, 'Sotiria' General Hospital of Chest Diseases, Athens 11527, Greece., Poulakou G; 3rd Department of Internal Medicine, 'Sotiria' General Hospital of Chest Diseases, National and Kapodistrian University of Athens, Athens 11527, Greece., Cobat A; St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY 10065.; Laboratory of Human Genetics of Infectious Diseases, Inserm U1163, Paris 75015, France.; Paris Cité University, Imagine Institute, Paris 75015, France., Casanova JL; St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY 10065.; Laboratory of Human Genetics of Infectious Diseases, Inserm U1163, Paris 75015, France.; Paris Cité University, Imagine Institute, Paris 75015, France.; Pediatric Hematology-Immunology and Rheumatology Unit, Necker Hospital for Sick Children, Assistante Publique-Hôpitaux de Paris, Paris 75015, France.; HHMI, New York, NY 10065., Tamvakopoulos C; Division of Pharmacology-Pharmacotechnology, Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens 11527, Greece., Andreakos E; Laboratory of Immunobiology, Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens 11527, Greece. |
| Πηγή: | Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2026 Jun 09; Vol. 123 (23), pp. e2534726123. Date of Electronic Publication: 2026 Jun 01. |
| Τύπος έκδοσης: | Journal Article |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: Washington, DC : National Academy of Sciences |
| Ιατρικοί όροι (MeSH): | Fatty Acids, Unsaturated*/metabolism , COVID-19*, Hydroxyeicosatetraenoic Acids/blood ; Hydroxyeicosatetraenoic Acids/metabolism ; Cytokines/metabolism ; Fatty Acids, Omega-6/metabolism ; Fatty Acids, Omega-3/metabolism ; Humans ; SARS-CoV-2 ; Severity of Illness Index ; Male ; Female ; Lipidomics ; Inflammation |
| Περίληψη: | Severe respiratory infections such as COVID-19 are characterized by excessive inflammation leading to the development of pneumonia and acute respiratory distress syndrome. Bioactive lipid mediators (LMs) derived from ω6 and ω3 polyunsaturated fatty acids are central to the regulation of inflammation, controlling both its initiation and resolution. Still, their role in viral infections remains underexplored. By employing a holistic approach involving the analysis of white blood cell transcriptomes, targeted lipidomics, cytokine and immune cell profiling, we now show that LM patterns around hospital admission are profoundly altered in COVID-19, correlate with inflammatory responses, and stratify patients according to disease severity. Central to this are CYP450-derived LMs, such as 20-HETE, and lipoxygenase- or nonenzymatic-associated LMs such as 15-HETE, both exhibiting vasoactive function, along with lipid peroxidation metabolites such as 10-HDOHE. Among them, increased 20-HETE appears to be a promising prognostic biomarker for ICU admission and a potential therapeutic target for severe COVID-19 disease. Our study emphasizes the importance of LM patterns in COVID-19 pathophysiology and sheds light into the broader immune mechanisms beyond cytokines driving viral pneumonia in humans. |
| Competing Interests: | Competing interests statement:Evangelos Andreakos has received research support for unrelated research from BioNtech and Janssen. The remaining authors declare no competing interests. |
| Grant Information: | 779295 EC | HORIZON EUROPE Framework Programme (Horizon Europe); 101057100 EC | HORIZON EUROPE Framework Programme (Horizon Europe); 1574 Hellenic Foundation for Research and Innovation (HFRI) |
| Contributed Indexing: | Keywords: COVID-19; PUFAs; hyperinflammation; innate immune response; lipid mediators |
| Substance Nomenclature: | 0 (Hydroxyeicosatetraenoic Acids) 0 (Cytokines) 0 (Fatty Acids, Unsaturated) 79551-86-3 (20-hydroxy-5,8,11,14-eicosatetraenoic acid) 0 (Fatty Acids, Omega-6) 0 (Fatty Acids, Omega-3) |
| Entry Date(s): | Date Created: 20260601 Date Completed: 20260603 Latest Revision: 20260730 |
| Update Code: | 20260730 |
| PubMed Central ID: | PMC13250500 |
| DOI: | 10.1073/pnas.2534726123 |
| PMID: | 42224585 |
| Βάση Δεδομένων: | MEDLINE |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: cmedm DbLabel: MEDLINE An: 42224585 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Polyunsaturated fatty acid-derived lipid mediator patterns determine viral pneumonia severity and risk for critical COVID-19. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Papadaki+M%22">Papadaki M</searchLink>; Laboratory of Immunobiology, Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens 11527, Greece.<br /><searchLink fieldCode="AU" term="%22Pavlos+E%22">Pavlos E</searchLink>; Laboratory of Immunobiology, Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens 11527, Greece.; Division of Basic Sciences, University of Crete Medical School, Heraklion 71110, Greece.<br /><searchLink fieldCode="AU" term="%22Dubourdeau+M%22">Dubourdeau M</searchLink>; Ambiotis Société par Actions Simplifiée, Toulouse 31400, France.<br /><searchLink fieldCode="AU" term="%22Bailif+V%22">Bailif V</searchLink>; Ambiotis Société par Actions Simplifiée, Toulouse 31400, France.<br /><searchLink fieldCode="AU" term="%22Badirou+K%22">Badirou K</searchLink>; Ambiotis Société par Actions Simplifiée, Toulouse 31400, France.<br /><searchLink fieldCode="AU" term="%22Gély+CA%22">Gély CA</searchLink>; Ambiotis Société par Actions Simplifiée, Toulouse 31400, France.<br /><searchLink fieldCode="AU" term="%22Galani+IE%22">Galani IE</searchLink>; Laboratory of Immunobiology, Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens 11527, Greece.<br /><searchLink fieldCode="AU" term="%22Papelis+D%22">Papelis D</searchLink>; Division of Pharmacology-Pharmacotechnology, Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens 11527, Greece.<br /><searchLink fieldCode="AU" term="%22Kamperi+N%22">Kamperi N</searchLink>; Division of Pharmacology-Pharmacotechnology, Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens 11527, Greece.<br /><searchLink fieldCode="AU" term="%22Triantafyllia+V%22">Triantafyllia V</searchLink>; Laboratory of Immunobiology, Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens 11527, Greece.<br /><searchLink fieldCode="AU" term="%22Siouti+E%22">Siouti E</searchLink>; Laboratory of Immunobiology, Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens 11527, Greece.<br /><searchLink fieldCode="AU" term="%22Salagianni+M%22">Salagianni M</searchLink>; Laboratory of Immunobiology, Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens 11527, Greece.<br /><searchLink fieldCode="AU" term="%22Manioudaki+M%22">Manioudaki M</searchLink>; Laboratory of Immunobiology, Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens 11527, Greece.<br /><searchLink fieldCode="AU" term="%22Paschalidis+N%22">Paschalidis N</searchLink>; Center of Basic Research, Biomedical Research Foundation of the Academy of Athens, Athens 11527, Greece.; Greek Genome Center, Biomedical Research Foundation Academy of Athens, Athens 11527, Greece.<br /><searchLink fieldCode="AU" term="%22Vatsellas+G%22">Vatsellas G</searchLink>; Center of Basic Research, Biomedical Research Foundation of the Academy of Athens, Athens 11527, Greece.; Greek Genome Center, Biomedical Research Foundation Academy of Athens, Athens 11527, Greece.<br /><searchLink fieldCode="AU" term="%22Koukaki+E%22">Koukaki E</searchLink>; Intensive Care Unit, 1st Department of Respiratory Medicine, National and Kapodistrian University of Athens, Medical School, 'Sotiria' General Hospital of Chest Diseases, Athens 11527, Greece.<br /><searchLink fieldCode="AU" term="%22Rapti+V%22">Rapti V</searchLink>; 3rd Department of Internal Medicine, 'Sotiria' General Hospital of Chest Diseases, National and Kapodistrian University of Athens, Athens 11527, Greece.<br /><searchLink fieldCode="AU" term="%22Thanos+D%22">Thanos D</searchLink>; Center of Basic Research, Biomedical Research Foundation of the Academy of Athens, Athens 11527, Greece.; Greek Genome Center, Biomedical Research Foundation Academy of Athens, Athens 11527, Greece.<br /><searchLink fieldCode="AU" term="%22Rovina+N%22">Rovina N</searchLink>; Intensive Care Unit, 1st Department of Respiratory Medicine, National and Kapodistrian University of Athens, Medical School, 'Sotiria' General Hospital of Chest Diseases, Athens 11527, Greece.<br /><searchLink fieldCode="AU" term="%22Poulakou+G%22">Poulakou G</searchLink>; 3rd Department of Internal Medicine, 'Sotiria' General Hospital of Chest Diseases, National and Kapodistrian University of Athens, Athens 11527, Greece.<br /><searchLink fieldCode="AU" term="%22Cobat+A%22">Cobat A</searchLink>; St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY 10065.; Laboratory of Human Genetics of Infectious Diseases, Inserm U1163, Paris 75015, France.; Paris Cité University, Imagine Institute, Paris 75015, France.<br /><searchLink fieldCode="AU" term="%22Casanova+JL%22">Casanova JL</searchLink>; St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY 10065.; Laboratory of Human Genetics of Infectious Diseases, Inserm U1163, Paris 75015, France.; Paris Cité University, Imagine Institute, Paris 75015, France.; Pediatric Hematology-Immunology and Rheumatology Unit, Necker Hospital for Sick Children, Assistante Publique-Hôpitaux de Paris, Paris 75015, France.; HHMI, New York, NY 10065.<br /><searchLink fieldCode="AU" term="%22Tamvakopoulos+C%22">Tamvakopoulos C</searchLink>; Division of Pharmacology-Pharmacotechnology, Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens 11527, Greece.<br /><searchLink fieldCode="AU" term="%22Andreakos+E%22">Andreakos E</searchLink>; Laboratory of Immunobiology, Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens 11527, Greece. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227505876%22">Proceedings of the National Academy of Sciences of the United States of America</searchLink> [Proc Natl Acad Sci U S A] 2026 Jun 09; Vol. 123 (23), pp. e2534726123. <i>Date of Electronic Publication: </i>2026 Jun 01. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: Language Label: Language Group: Lang Data: English – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22National+Academy+of+Sciences%22">National Academy of Sciences </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7505876 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1091-6490 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200278424%22">00278424 </searchLink><i>NLM ISO Abbreviation: </i>Proc Natl Acad Sci U S A <i>Subsets: </i>MEDLINE – Name: PublisherInfo Label: Imprint Name(s) Group: PubInfo Data: <i>Original Publication</i>: Washington, DC : National Academy of Sciences – Name: SubjectMESH Label: MeSH Terms Group: Su Data: <searchLink fieldCode="MM" term="%22Fatty+Acids%2C+Unsaturated%22">Fatty Acids, Unsaturated*</searchLink>/<searchLink fieldCode="MM" term="%22Fatty+Acids%2C+Unsaturated+metabolism%22">metabolism</searchLink> <br /><searchLink fieldCode="MM" term="%22COVID-19%22">COVID-19*</searchLink><br /><searchLink fieldCode="MH" term="%22Hydroxyeicosatetraenoic+Acids%22">Hydroxyeicosatetraenoic Acids</searchLink>/<searchLink fieldCode="MH" term="%22Hydroxyeicosatetraenoic+Acids+blood%22">blood</searchLink> ; <searchLink fieldCode="MH" term="%22Hydroxyeicosatetraenoic+Acids%22">Hydroxyeicosatetraenoic Acids</searchLink>/<searchLink fieldCode="MH" term="%22Hydroxyeicosatetraenoic+Acids+metabolism%22">metabolism</searchLink> ; <searchLink fieldCode="MH" term="%22Cytokines%22">Cytokines</searchLink>/<searchLink fieldCode="MH" term="%22Cytokines+metabolism%22">metabolism</searchLink> ; <searchLink fieldCode="MH" term="%22Fatty+Acids%2C+Omega-6%22">Fatty Acids, Omega-6</searchLink>/<searchLink fieldCode="MH" term="%22Fatty+Acids%2C+Omega-6+metabolism%22">metabolism</searchLink> ; <searchLink fieldCode="MH" term="%22Fatty+Acids%2C+Omega-3%22">Fatty Acids, Omega-3</searchLink>/<searchLink fieldCode="MH" term="%22Fatty+Acids%2C+Omega-3+metabolism%22">metabolism</searchLink> ; <searchLink fieldCode="MH" term="%22Humans%22">Humans</searchLink> ; <searchLink fieldCode="MH" term="%22SARS-CoV-2%22">SARS-CoV-2</searchLink> ; <searchLink fieldCode="MH" term="%22Severity+of+Illness+Index%22">Severity of Illness Index</searchLink> ; <searchLink fieldCode="MH" term="%22Male%22">Male</searchLink> ; <searchLink fieldCode="MH" term="%22Female%22">Female</searchLink> ; <searchLink fieldCode="MH" term="%22Lipidomics%22">Lipidomics</searchLink> ; <searchLink fieldCode="MH" term="%22Inflammation%22">Inflammation</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Severe respiratory infections such as COVID-19 are characterized by excessive inflammation leading to the development of pneumonia and acute respiratory distress syndrome. Bioactive lipid mediators (LMs) derived from ω6 and ω3 polyunsaturated fatty acids are central to the regulation of inflammation, controlling both its initiation and resolution. Still, their role in viral infections remains underexplored. By employing a holistic approach involving the analysis of white blood cell transcriptomes, targeted lipidomics, cytokine and immune cell profiling, we now show that LM patterns around hospital admission are profoundly altered in COVID-19, correlate with inflammatory responses, and stratify patients according to disease severity. Central to this are CYP450-derived LMs, such as 20-HETE, and lipoxygenase- or nonenzymatic-associated LMs such as 15-HETE, both exhibiting vasoactive function, along with lipid peroxidation metabolites such as 10-HDOHE. Among them, increased 20-HETE appears to be a promising prognostic biomarker for ICU admission and a potential therapeutic target for severe COVID-19 disease. Our study emphasizes the importance of LM patterns in COVID-19 pathophysiology and sheds light into the broader immune mechanisms beyond cytokines driving viral pneumonia in humans. – Name: Abstract Label: Competing Interests Group: Ab Data: Competing interests statement:Evangelos Andreakos has received research support for unrelated research from BioNtech and Janssen. The remaining authors declare no competing interests. – Name: GrantInfo Label: Grant Information Group: Grant Data: 779295 EC | HORIZON EUROPE Framework Programme (Horizon Europe); 101057100 EC | HORIZON EUROPE Framework Programme (Horizon Europe); 1574 Hellenic Foundation for Research and Innovation (HFRI) – Name: SubjectMinor Label: Contributed Indexing Group: Data: <i>Keywords: </i>COVID-19; PUFAs; hyperinflammation; innate immune response; lipid mediators – Name: NumberCAS Label: Substance Nomenclature Group: ID Data: 0 (Hydroxyeicosatetraenoic Acids)<br />0 (Cytokines)<br />0 (Fatty Acids, Unsaturated)<br />79551-86-3 (20-hydroxy-5,8,11,14-eicosatetraenoic acid)<br />0 (Fatty Acids, Omega-6)<br />0 (Fatty Acids, Omega-3) – Name: DateEntry Label: Entry Date(s) Group: Date Data: <i>Date Created: </i>20260601 <i>Date Completed: </i>20260603 <i>Latest Revision: </i>20260730 – Name: DateUpdate Label: Update Code Group: Date Data: 20260730 – Name: PubmedCentralID Label: PubMed Central ID Group: ID Data: PMC13250500 – Name: DOI Label: DOI Group: ID Data: 10.1073/pnas.2534726123 – Name: AN Label: PMID Group: ID Data: 42224585 |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=cmedm&AN=42224585 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1073/pnas.2534726123 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e2534726123 Subjects: – SubjectFull: Hydroxyeicosatetraenoic Acids blood Type: general – SubjectFull: Hydroxyeicosatetraenoic Acids metabolism Type: general – SubjectFull: Cytokines metabolism Type: general – SubjectFull: Fatty Acids, Omega-6 metabolism Type: general – SubjectFull: Fatty Acids, Omega-3 metabolism Type: general – SubjectFull: Humans Type: general – SubjectFull: SARS-CoV-2 Type: general – SubjectFull: Severity of Illness Index Type: general – SubjectFull: Male Type: general – SubjectFull: Female Type: general – SubjectFull: Lipidomics Type: general – SubjectFull: Inflammation Type: general – SubjectFull: Fatty Acids, Unsaturated metabolism Type: general – SubjectFull: COVID-19 Type: general Titles: – TitleFull: Polyunsaturated fatty acid-derived lipid mediator patterns determine viral pneumonia severity and risk for critical COVID-19. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Papadaki M – PersonEntity: Name: NameFull: Pavlos E – PersonEntity: Name: NameFull: Dubourdeau M – PersonEntity: Name: NameFull: Bailif V – PersonEntity: Name: NameFull: Badirou K – PersonEntity: Name: NameFull: Gély CA – PersonEntity: Name: NameFull: Galani IE – PersonEntity: Name: NameFull: Papelis D – PersonEntity: Name: NameFull: Kamperi N – PersonEntity: Name: NameFull: Triantafyllia V – PersonEntity: Name: NameFull: Siouti E – PersonEntity: Name: NameFull: Salagianni M – PersonEntity: Name: NameFull: Manioudaki M – PersonEntity: Name: NameFull: Paschalidis N – PersonEntity: Name: NameFull: Vatsellas G – PersonEntity: Name: NameFull: Koukaki E – PersonEntity: Name: NameFull: Rapti V – PersonEntity: Name: NameFull: Thanos D – PersonEntity: Name: NameFull: Rovina N – PersonEntity: Name: NameFull: Poulakou G – PersonEntity: Name: NameFull: Cobat A – PersonEntity: Name: NameFull: Casanova JL – PersonEntity: Name: NameFull: Tamvakopoulos C – PersonEntity: Name: NameFull: Andreakos E IsPartOfRelationships: – BibEntity: Dates: – D: 09 M: 06 Text: 2026 Jun 09 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1091-6490 Numbering: – Type: volume Value: 123 – Type: issue Value: 23 Titles: – TitleFull: Proceedings of the National Academy of Sciences of the United States of America Type: main |
| ResultId | 1 |